DM programs bring relief to migraine sufferers.
D000700:Analgesics / Q000627:therapeutic use; D001364:Awareness; D006233:Persons with Disabilities; D019468:Disease Management; D017723:Drug Utilization Review; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D010353:Patient Education as Topic; D011788:Quality of Life; D016896:Treatment Outcome; D014481:United States
D000700:Analgesics